Larsucosterol

Cat. No.: IBDI-432271

Larsucosterol (DUR-928), a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol as a potent endogenous regulator decreases lipogenesis. Larsucosterol inhibits the cholesterol biosynthesis via decreasing mRNA levels and inhibiting the activation of SREBP-1.

Product Details

Target	Endogenous Metabolite
Molecular Weight	482.72
Synonyms	DUR-928
SMILES	C[[email protected]@]12[[email protected]](CC[[email protected]]2([H])[[email protected]](C)CCCC(C)(O)C)([H])[[email protected]@]3([H])[[email protected]@](CC1)([H])[[email protected]@]4(C(C[[email protected]](CC4)OS(=O)(O)=O)=CC3)C

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.